Inovio Pharmaceuticals (INO) Revenue (2009 - 2026)
Inovio Pharmaceuticals (INO) posted Revenue of $298,901 for Q3 2026.
Analysis
Inovio Pharmaceuticals (INO) Revenue (2009 - 2026) Analysis & Trends
For FY2025, Inovio Pharmaceuticals' Revenue came in at $65,343, down 70.0% from FY2024.
- Annual Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -61.2% (FY2020 to FY2025).
- In prior years, Inovio Pharmaceuticals' Revenue was $217,756 in FY2024 (-73.8%), $832,010 in FY2023 (-91.9%), $10.26 million in FY2022 (+478.2%) and $1.77 million in FY2021 (-76.1%).
- The Q3 2026 figure stands as the highest quarterly Revenue since Q3 2023.
- The strongest year-over-year quarter for Revenue in the past five years was Q2 2022, with growth of 187.5%; the weakest was Q3 2023, with a decline of 95.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 212,806.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 24.40 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 25.40 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 17.40 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 18.09 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Inovio Pharmaceuticals | 174.42 Mn | -6.81 Mn | - | 298,901.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 298,901.00 |
| Mar 31, 2025 | 65,343.00 |
| Dec 31, 2024 | 116,994.00 |
| Jun 30, 2024 | 100,762.00 |
| Dec 31, 2023 | 102,651.00 |
| Sep 30, 2023 | 388,446.00 |
| Jun 30, 2023 | 225,971.00 |
| Mar 31, 2023 | 114,943.00 |
| Dec 31, 2022 | 124,666.00 |
| Sep 30, 2022 | 9.15 Mn |
| Jun 30, 2022 | 784,395.00 |
| Mar 31, 2022 | 199,074.00 |
| Dec 31, 2021 | 839,115.00 |
| Sep 30, 2021 | 291,698.00 |
| Jun 30, 2021 | 272,824.00 |
| Mar 31, 2021 | 371,120.00 |
| Dec 31, 2020 | 5.58 Mn |
| Sep 30, 2020 | 236,178.00 |
| Jun 30, 2020 | 267,187.00 |
| Mar 31, 2020 | 1.33 Mn |
API Access
Inovio Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=INO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();